These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9744700)

  • 21. Intestinal lymphangiectasia--a report of three Chinese children in Malaysia.
    Lee WS; Boey CC; Goh AY; Chang KW; Iyngkaran N
    Singapore Med J; 1998 Sep; 39(9):418-21. PubMed ID: 9885723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refractory primary intestinal lymphangiectasia effectively managed with subcutaneous octreotide.
    Halim A; Youd P; Thorpe J; Halim I
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33837021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Intestinal Lymphangiectasia Manifested as Unusual Edemas and Effusions: A Case Report.
    Wang X; Jin H; Wu W
    Medicine (Baltimore); 2016 Mar; 95(10):e2849. PubMed ID: 26962779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma.
    Broder S; Callihan TR; Jaffe ES; DeVita VT; Strober W; Bartter FC; Waldmann TA
    Gastroenterology; 1981 Jan; 80(1):166-8. PubMed ID: 7450403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Small bowel pseudo-obstruction revealing an early scleroderma. Long-term efficacy of octreotide and erythromycin].
    Lecomte T; Cavicchi M; Delchier JC
    Gastroenterol Clin Biol; 2000 Mar; 24(3):361-3. PubMed ID: 10804347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
    Landvoigt MT; Mullett CJ
    Pediatr Crit Care Med; 2006 May; 7(3):245-8. PubMed ID: 16575348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired intestinal lymphangiectasia successfully treated with a low-fat and medium-chain triacylglycerol-enriched diet in a patient with liver transplantation.
    Biselli M; Andreone P; Gramenzi A; Cursaro C; Lorenzini S; Bonvicini F; Bernardi M
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):561-4. PubMed ID: 16607157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe Refractory Anemia in Primary Intestinal Lymphangiectasia. A Case Report.
    Balaban VD; Popp A; Grasu M; Vasilescu F; Jinga M
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):369-73. PubMed ID: 26405709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report.
    Berzigotti A; Magalotti D; Cocci C; Angeloni L; Pironi L; Zoli M
    Dig Liver Dis; 2006 Feb; 38(2):138-42. PubMed ID: 16389001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Octreotide for management of chylothorax following bidirectional Glenn in a three-month-old infant.
    Wright SB; Mainwaring RD
    J Card Surg; 2009; 24(2):216-8. PubMed ID: 19267835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital chylothorax treated with octreotide.
    Sahin Y; Aydin D
    Indian J Pediatr; 2005 Oct; 72(10):885-8. PubMed ID: 16272667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe congenital chylothorax treated with octreotide.
    Young S; Dalgleish S; Eccleston A; Akierman A; McMillan D
    J Perinatol; 2004 Mar; 24(3):200-2. PubMed ID: 15044932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained release octreotide may have a role in the treatment of malignant bowel obstruction.
    Massacesi C; Galeazzi G
    Palliat Med; 2006 Oct; 20(7):715-6. PubMed ID: 17060271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report.
    Sivasli E; Dogru D; Aslan AT; Yurdakok M; Tekinalp G
    J Perinatol; 2004 Apr; 24(4):261-2. PubMed ID: 15067298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary intestinal lymphangiectasia (Waldmann's disease).
    Vignes S; Bellanger J
    Orphanet J Rare Dis; 2008 Feb; 3():5. PubMed ID: 18294365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital pulmonary lymphangiectasia in a newborn: a response to autologous blood therapy.
    Akcakus M; Koklu E; Bilgin M; Kurtoglu S; Altunay L; Canpolat M; Budak N
    Neonatology; 2007; 91(4):256-9. PubMed ID: 17568156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent hemolytic uremic syndrome associated with intestinal lymphangiectasia.
    Kalman S; Bakkaloğlu S; Dalgiç B; Ozkaya O; Söylemezoğlu O; Buyan N
    J Nephrol; 2007; 20(2):246-9. PubMed ID: 17514630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is octreotide treatment useful in patients with congenital chylothorax?
    Horvers M; Mooij CF; Antonius TA
    Neonatology; 2012; 101(3):225-31. PubMed ID: 22076538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scopolamine butylbromide plus octreotide in unresponsive bowel obstruction.
    Mercadante S
    J Pain Symptom Manage; 1998 Nov; 16(5):278-80. PubMed ID: 9846021
    [No Abstract]   [Full Text] [Related]  

  • 40. Chylous ascites, intestinal lymphangiectasia and the 'yellow-nail' syndrome.
    Duhra PM; Quigley EM; Marsh MN
    Gut; 1985 Nov; 26(11):1266-9. PubMed ID: 4065700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.